Display Settings:

Format

Send to:

Choose Destination
    J Neurol. 2006 Sep;253 Suppl 5:V64-5.

    Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).

    Source

    Friedrich-Baur-Institut, Medizinischen Fakultät, Neurologischen Klinik und Poliklinik, Ludwig Maximilians Universität München, Ziemssenstrasse 1, 80336, München, Germany. dieter.pongratz@fbs.med.uni-muenchen.de

    Erratum in

    • J Neurol. 2008 Feb;255(2):308.

    Abstract

    Polymyositis, dermatomyositis, and inclusion body myositis are idiopathic inflammatory myopathies of unknown etiology with autoimmune pathogenesis. For choosing an individual and efficient therapy, diagnostic assignment is an important factor. Therapeutic options in dermatomyositis and polymyositis include corticosteroids and immunosuppressives. Intravenous immunoglobulins are only needed in special cases. In inclusion body myositis, corticosteroids and immunosuppressives are not successful. At the moment intravenous immunoglobulins are the only therapeutic possibility.

    PMID:
    16998756
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk